A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 24, 2014

Primary Completion Date

June 13, 2016

Study Completion Date

March 3, 2017

Conditions

Chronic Hepatitis CDecompensated CirrhosisHepatitis C Virus

Interventions

DRUG

ombitasvir/paritaprevir/ritonavir

tablet; paritaprevir co-formulated with ritonavir and ombitasvir

DRUG

dasabuvir

tablet

DRUG

ribavirin

tablet